PKCα and PKCβ cooperate functionally in CD3-induced de novo IL-2 mRNA transcription  by Christina, Lutz-Nicoladoni et al.
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a  b  s  t  r  a  c  t
The  physiological  functions  of  PKC  and  PKC  isotypes  downstream  of the antigen  receptor  have  been
deﬁned  in CD3+ T cells.  In contrast,  no  function  of  the  second  conventional  PKC  member,  PKC,  has  been
described  yet  in  T cell  antigen  receptor  signalling.  To investigate  the  hypothesis  that  both  conventional
PKC  and  PKC  isotypes  may  have  overlapping  functions  in  T cell  activation  signalling,  we  generated
mice  that  lacked  the  genes  for  both  isotypes.  We  found  that  PKC˛−/−/ˇ−/− animals  are  viable, live normaleywords:
KC
KC
 cell activation
L-2  transcription
life  spans  and  display  normal  T  cell  development.  However,  these  animals  possess  additive  defects  in  T
cell  responses  in comparison  to animals  that  carry  single  mutations  in these  genes. Our  studies  demon-
strate  that  the  activities  of PKC  and  PKC  converge  to  regulate  IL-2  cytokine  responses  in  anti-CD3
stimulated  primary  mouse  T cells.  Here,  we  present  genetic  evidence  that  PKC  and  PKC  cooperate  in
IL-2  transcriptional  transactivation  in primary  mouse  T cells  independently  of the  actions  of PKC.ytokine response
. Introduction
Protein kinase C (PKC) comprises a closely related family of ser-
ne/threonine protein kinases that were originally discovered by
ishizuka and colleagues in 1977 [1]. The PKC family consists of
ine isotypes that are expressed in a wide range of cell types and
issues [2]. According to both the structures of the variable regu-
atory domains and the cofactor dependencies, PKCs are classiﬁed
nto the following categories: conventional PKCs (cPKCs; , , ),
ovel PKCs (nPKCs; , , , ) and atypical PKCs (aPKCs; 	, 
) [3].
PKCs require Ca2+ and diacylglycerol (DAG) for activation; how-
ver, nPKCs are Ca2+ independent and aPKCs do not require Ca2+
r DAG for their activation. In T cells, all isotypes except PKC
Abbreviations: AP1, activator protein 1; cpm, counts per minute; EMSA, elec-
rophoretic mobility shift assay; FACS, ﬂuorescence activated cell sorter; ERK,
xtracellular regulated kinase; IL-2, interleukin-2; IFN, interferon gamma; IB,
nhibitor of NFB; IKK, IB kinase; LMWI,  low molecular weight inhibitor; NFAT,
uclear  factor of T cell activation; NFB, nuclear factor of B; NP-40, 2-nonen-1-yl
uccinic  anhydride; PDBu, phorbol 12,13-dibutyrate; PKC, protein kinase C; PKD,
rotein kinase D; qRT-PCR, quantitative real time polymerase chain reaction; TCR,
 cell receptor; WB,  western blot analysis.
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are expressed. The expression of multiple PKC isotypes in a given
cell suggests functional redundancy. Therefore, the pharmaceu-
tical industry is focused upon the generation of low molecular
weight inhibitors (LMWIs) that speciﬁcally inhibit selected PKC
isotypes or combinations of multiple PKCs in order to suppress T
cell-dependent immune responses that are concomitant with organ
transplantation or autoimmune diseases [4,5].
In gene knockout experiments, two  isotypes of PKC, PKC
and PKC, were shown to have physiological and non-redundant
roles in antigen receptor-mediated signalling in primary CD3+ T
lymphocytes. Upon T cell engagement, PKC is recruited to the
immunological synapse [6,7]. PKC was shown to function down-
stream of the antigen receptor as a critical signal strength regulator
for the transactivation of the NFB, AP1, and NFAT transcription
factors [8,9]. PKC appears to be required particularly for the devel-
opment of robust immune responses that are controlled by both
Th2 [10,11] and Th17 [12,13] cells.
By contrast, PKC was  shown to be essential for Th1 cell-
dependent immune responses [14]. PKC is highly expressed in T
lymphocytes and translocates to the plasma membrane following T
cell activation [15,16]. Earlier studies, in which transgenic mice that
overexpressed PKC were used, deﬁned an important role for this
Open access under CC BY-NC-ND license.isotype in T cell function [17]. Using the established PKC knockout
mice [18], our group studied the physiological and non-redundant
functions of PKC in T cell signalling. PKC−/− mice are born in
expected Mendelian ratios, are fertile, appear to be healthy, are
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natomically normal and have normal life spans compared to wild
ype littermates. The development of CD3+ T cells in these mice
s normal, as are the subset distributions (CD4+/CD8+ ratio). How-
ver, PKC-deﬁcient CD3+ T cells showed impaired proliferation
pon T cell receptor (TCR) stimulation, while IL-2 production and
L-2 signalling were only slightly impaired. PKC was shown to
e essential for T cell dependent IFN- production and IgG2a/2b
ntibody responses in vivo [14].
The functions of PKC are well characterised in both the
mmune receptor and insulin receptor signalling pathways [19,20].
KC knockout mice, which are also viable, fertile and born in
he expected Mendelian frequencies, demonstrate deﬁcient B cell
evelopment, reduced numbers of B1 lymphocytes and impaired
umoral immune responses [21]. In T cells, the role of PKC in
igration, which is mediated by the 2 integrin receptor LFA-1, has
een described [22,23]. Additionally, a role for PKC in  TCR induced
ignalling, IL-2 expression and IL-2 secretion was observed in T cell
ines [24,25]. However, our group was the ﬁrst to investigate the
ole of PKC in primary mature CD3+ T cells, and in contrast to the
esults that were obtained with different cell lines, we showed that
KC is not essential for either the proliferation of or IL-2 secre-
ion in T cells, even though this PKC isotype is highly expressed in
 cells [26]. These data suggest that other PKC isotypes may com-
ensate for PKC deﬁciency, which results in normal biological T
ell responses.
These data prompted us to generate a line of PKC/ double
nockout mice to investigate the potentially overlapping roles of
hese two cPKC isotypes in CD3-dependent activation processes.
he phenotypic characterisation of T cell-dependent immune
esponses of PKC˛−/−/ˇ−/− mice, in comparison to mice that carry
ingle deﬁciencies and to wild type controls, revealed that PKC
nd PKC cooperate functionally to mediate IL-2 gene expression.
.  Materials and methods
Generation  and genotyping of PKC−/−−/− double knockout
ice: C57BL/6 J PKC−/−−/− mice were generated by crossing
KC−/− [18] with PKC−/− mice [21]. Tail DNA was extracted and
he PKC and PKC alleles were genotyped by PCR, using the fol-
owing primers: for the alpha allele, PKC3′ (5′-CCT GGT GGC AAT
GG TGA TCT ACA C-3′) and PKC5′ (5′-GAG CCC TTG GGT TTC AAG
AT AGA-3′), which yielded either a 600 bp wild type fragment or
 1.7 kb mutant fragment; for the beta allele, PKC1 (5′-CAG GGT
GA ATT GCC ATC CTC CA-3′), PKC2 (5′-CCC CAC CCC CTC CTT CTT
CT-3′) and MO13 (5′-CTT GGG TGG AGA GGC TAT TC-3′), which
ielded a 900 bp wild type fragment and a 1.3 kb mutant fragment.
or all experiments, mice were aged 6–10 weeks. All mice were
oused under SPF conditions at the mouse facility of the Medical
niversity of Innsbruck. All experiments complied with the current
aws of Austria.
.1.  FACS analysis of cell subsets and cell surface activation
arkers
Single-cell suspensions from freshly isolated thymi, spleens and
ymph nodes were incubated on ice in staining buffer (phosphate-
uffered saline containing 2% foetal calf serum), with FITC-, PE-
r APC-conjugated antibodies to identify T cell subsets. CD3, CD19,
D4, CD8 antibodies were obtained from Caltag Laboratories. CD25,
D44, CD62L and CD69 antibodies (BD/Pharmingen) were used
o stain activated CD3+ T cells. Surface marker staining was  ana-
ysed using a FACSCaliburTM ﬂow cytometer (Becton Dickinson) and
ellQuestProTM software. The results are shown as the mean ± SEM
f at least 3 independent experiments.y Letters 151 (2013) 31– 38
2.2.  Analysis of proliferation responses
Naive CD3+ T cells were negatively selected from pooled spleen
and lymph node cell suspensions with mouse T cell enrichment
columns (R&D Systems). T cell populations consisted typically
of 95% CD3+ cells, as determined by staining and ﬂow cytome-
try. For anti-CD3 stimulations, T cells (2.5 × 105) were added in
200 l of proliferation medium (RPMI supplemented with 10%
FCS (Life Technologies), 2 mM l-glutamine (Life Technologies) and
50 U/ml penicillin/streptomycin (Biochrom)), in duplicate, to 96-
well plates that were precoated with anti-CD3 antibody (clone
145-2C11, 10 g/ml). Where indicated, IL-2 (ﬁnal concentration
40 U/ml) or soluble anti-CD28 (clone 37.51, 1 g/ml; BD Pharmin-
gen) were added. Alternatively, PDBu (10 ng/ml; Sigma) plus the
Ca2+ ionophore ionomycin (125 ng/ml; Sigma) were used. After
48 h, cells were pulsed for 18 h with [3H]thymidine (1 Ci/well) and
were harvested onto a ﬁlter. The incorporation of [3H]thymidine
was measured with a Matrix 96 direct beta counter system. For
surface expression analysis of activation markers, cells were incu-
bated for 20 or 48 h as indicated and were subsequently stained for
FACS analysis with the above-mentioned antibodies.
2.3. Analysis of cytokine production
For cytokine secretion analysis, cells were activated for 20 or
48 h as indicated. After 48 h, supernatants were collected and were
frozen in aliquots for later measurement of secreted cytokines.
To determine total IL-2 production, cells were frozen and thawed
three times to allow for the detection of non secreted IL-2. The
concentrations of cytokines were determined with BioPlex tech-
nology (BioRad). The results are shown as the mean ± SD of at least
3 experiments.
2.4. RNA transcript analysis
Naive  CD3+ T cells were negatively selected from pooled spleen
and lymph node cell suspensions with mouse T cell enrichment
columns (R&D Systems) and were rested for 12 h in serum free
X-vivo 20 medium (Cambrex) prior to stimulation with anti-CD3
(clone 145-2C11) antibody (10 g/ml precoated), with or without
soluble anti CD28 antibody (clone 37.51, 1 g/ml, BD Pharmin-
gen), for 0 to 20 h. Total RNA was  isolated using the Qiagen RNeasy
kit. The ﬁrst-strand cDNA synthesis was performed using oligo(dT)
primers (Promega) with the Qiagen Omniscript RT kit, according
to the instructions from the supplier. The expression analysis was
performed using real-time PCR with an ABI PRIM 7000 Sequence
Detection System (Applied Biosystems) and TaqMan gene expres-
sion assays, and all expression patterns were normalised to that of
Gapdh. The expression levels of wild type unstimulated cells were
arbitrarily set to 1. To determine IL-2 decay, Actinomycin D (Sigma)
was used to stop transcription and cells were harvested at various
time points as indicated. Cells were lysed in Nucleic Acid Puriﬁca-
tion Lysis Solution (Applied Biosystems) according to the protocol
and were stored at −80 ◦C.
2.5.  Western blot analysis
T  cells were incubated either with medium alone or were
stimulated with solid-phase hamster anti-CD3 (clone 145–2C11),
with or without hamster anti-CD28 (clone 37.51; BD Pharmin-
gen) at 37 ◦C for various time periods. For short time stimulations,
both antibodies were added in soluble form and were crosslinked
with anti-hamster IgG1 (clone HIG-632; BD Pharmingen). Cells
were lysed in ice-cold lysis buffer (5 mM  NaP2P, 5 mM NaF, 5 mM
EDTA, 50 mM NaCl, 50 mM Tris (pH 7.3), 2% Nonidet P-40, and
50 g/ml each aprotinin and leupeptin) and were centrifuged at
nology Letters 151 (2013) 31– 38 33
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Table 1
Cell  subsets.
Wt PKC−/− PKC−/− PKC−/−−/−
Thymus
CD3+ 15.46 ± 2.05 16.75  ± 1.83 17.4 ± 1.14 15.54 ± 2.85
CD4+ 8.10 ± 2.13 8.91 ± 4.42 10.36 ± 3.15 8.82 ± 2.36
CD8+ 2.55 ± 0.43 2.35 ± 1.10 3.74 ± 0.60 3.33 ± 0.73
CD4+/CD8+ 83.61 ± 3.15 86.68 ± 6.39 83.74 ± 4.70 84.00 ± 3.87
Lymph  nodes
CD3+ 76.55 ± 5.63 69.45 ± 13.86 77.80 ± 7.15 79.33 ± 3.15
CD19+ 10.63 ± 7.24 13.54  ± 14.92 10.74  ± 9.62 10.96  ± 5.85
CD4+ 58.54 ± 10.08 57.35 ± 12.79 57.35 ± 15.04 57.22 ± 4.66
CD8+ 20.22 ± 1.85 15.39 ± 3.23 15.39 ± 3.49 23.16 ± 1.61
Spleen
CD3+ 30.35 ± 0.12 37.23 ± 1.23 42.26 ± 1.05 40.22 ± 2.58
CD19+ 53.06 ± 0.36 50.71 ± 2.36 43.06 ± 3.76 41.13 ± 0.71L.-N. Christina et al. / Immu
5,000 × g for 15 min  at 4 ◦C. Protein lysates were subjected to
estern blotting as previously described [8], using Abs against
KC (Upstate Biotechnology), PKC, PKC (all from Transduc-
ion Laboratories), PKC, DNA polymerase (all from Santa Cruz
iotechnology), NFATc (Afﬁnity Bioreagents), (p)S-32 IB, pan-IB,
p)Y-783 PLC1, (p)ERK, Fyn and PKB/AKT (all from Cell Signalling).
ll experiments were performed at least twice with similar out-
omes.
.6. Gel mobility shift assays
Nuclear  extracts were prepared from 1 × 107 cells that were
timulated as indicated. Brieﬂy, puriﬁed CD3+ cells were washed
n PBS and resuspended in 10 mM HEPES (pH7.9), 10 mM KCl,
.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT and protease inhibitors.
ells were incubated on ice for 15 min. Nonidet P-40 was added to a
nal concentration of 0.6%, the cells were vortexed vigorously, and
he mixtures were centrifuged for 5 min. The nuclear pellets were
ashed twice and resuspended in 20 mM HEPES (pH 7.9), 0.4 M
aCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and protease inhibitors,
nd the tubes were rocked for 30 min  at 4 ◦C. After centrifuga-
ion for 10 min, the supernatants were collected. Extract proteins
2 g) were incubated in binding buffer with 32P-labelled, double-
tranded oligonucleotide probes (NFB, 5′-GCC ATG GGG GGA TCC
CG AAG TCC-3′; AP1, 5′-CGC TTG ATG ACT CAG CCG GAA-3′; and
FAT, 5′-GCC CAA AGA GGA AAA TTT GTT TCA TAC AG-3′; AP1,
′-CGC TTG ATG ACT CAG CCG GAA-3′ (Nushift; Active Motif)). In
ach reaction, 3 × 105 cpm of labelled probe was used, and band-
hifts were resolved on 5% polyacrylamide gels. Supershifts were
erformed using the following antibodies AP1 cFos; NFATc; NFB
50 (Nushift; Active Motive). All experiments were performed at
east twice with similar outcomes.
.7. Apoptosis detection
Thymocyte  apoptosis was induced by the addition of the fol-
owing treatments: Con A (10 g/ml), PDBu (1 g/ml), ionomycin
1 g/ml), camptothecin (1 M),  etoposide (1 M),  dexamethasone
1 M),  staurosporin (100 nM), TCR crosslinking antibodies (anti
D3, 10 g/ml precoated, ±anti CD28 1 g/ml) or FasL (100 ng/ml)
nd Enhancer of FasL (1 g/ml). FasL and Enhancer for FasL
ere purchased from Alexis Pharmaceuticals, anti CD28 from BD
harmingen, all other agents were obtained from Sigma–Aldrich.
he percentages of viable cells were determined by propidium
odide staining at various time points, up to 68 h.
Total splenocytes were used to generate activated T cell blasts by
ncubation with Con A (2 g/ml) for 48 h, followed by IL-2 stimula-
ion (100 U/ml) for an additional 72 h in IMEM medium (Biochrom)
hat was supplemented with 10% FCS, 2 mM l-glutamine and
0 U/ml penicillin/streptomycin. After 5 days, activated T cell blasts
ere washed twice in medium, and viable cells were enriched by
ympholyteTM (Cedarlane) gradient centrifugation (viability >90%),
ollowed by an incubation in IMEM medium (supplemented with
0% FCS, 2 mM l-glutamine and 50 U/ml penicillin/streptomycin).
ctivation-induced cell death was challenged by the addition of dif-
erent concentrations of anti-CD3 cross-linking antibodies (clone
45-2C11; 0.1–10 g/ml) and apoptosis was induced by the addi-
ion of cross-linked recombinant FasL (100 ng/ml of FasL, plus
 g/ml of the enhancer for FasL). Eight hours after apoptosis induc-
ion, the cells were harvested and stained with Annexin V - FITC
Molecular Probes), anti-CD4-PE and anti-CD8-APC (Caltag). The
ercentage of apoptotic cells in each T cell subset was determined
y FACS analysis, using a FACSCalibur ﬂow cytometer (BD) and Cel-
QuestPro Software. The results are shown as the mean±SD of at
east 3 experiments.CD4+ 22.88 ± 0.10 24.13 ± 0.98 25.81 ± 3.17 29.20 ± 2.10
CD8+ 12.97 ± 2.00 10.36 ± 1.89 16.01 ± 2.06 16.36 ± 1.86
3. Results
3.1. Generation of PKC˛/  ˇ double knockout mice
We generated mice that lacked both cPKC isotypes by crossing
PKC−/− mice [18] with PKC−/− mice [21]; these mice were then
backcrossed onto the C57BL/6 background for more than 10 gen-
erations prior to use in experiments. Genotypes were determined
by PCR. The null mutations of PKC or PKC were conﬁrmed by
immunoblotting of whole cell lysates from naïve thymocytes and
peripheral CD3+ T cells, respectively (Fig. 1a). Neither the other
PKC isotypes that were normally expressed in CD3+ T cells nor
PKB/Akt were upregulated in the cells derived from PKC/ double-
deﬁcient mice. Fertility was  reduced in PKC/ double knockout
mice, although the mice were viable, appeared to be healthy and
lived normal lifespans. On average, double knockout mice were
slightly smaller when compared to wild type mice at 3 weeks of age
(mean body weight 83%), although this difference was  abrogated
by 6 weeks of age.
FACS  analysis of thymocyte populations in PKC/ double
knockout mice revealed that CD4+CD8+ double positive thymo-
cytes were able to differentiate normally with regards to numbers
of CD4+ and CD8+ T cells and CD3 expression (Table 1). Additionally,
the composition of peripheral T and B cell subsets was  unaltered in
PKC/ double knockout mice (Table 1).
3.2. Impaired TCR induced proliferation of PKC˛/ˇ
double-deﬁcient CD3+ T cells
To determine any potentially overlapping roles of PKC and
PKC we analysed the proliferative responses of freshly prepared
CD3+ T cells from wild type, PKC single knockout, PKC single
knockout and PKC/ double knockout mice. The proliferation
of PKC/ deﬁcient cells that were stimulated by anti-CD3, with
or without anti-CD28, was impaired to the same degree as in
PKC single knockout cells (Fig. 1b), as measured by 3H thymidine
uptake.
To exclude the proliferative defects being caused by deregulated
apoptosis we analysed both apoptotic sensitivity of thymocytes
following exposure to apoptotic stimuli (PDBu, ionomycin, dexa-
methasone, etoposide, camptothecin, staurosporin, concanavalin
A, anti CD3 or FasL) and AICD and/or Fasl induced apoptosis of CD4+
and CD8+ T-cell blasts derived from wild-type and double knockout
animals using CD3 engagement in vitro. Ex vivo survival of freshly
isolated PKC/ deﬁcient thymocytes was  unaffected (supplemen-
tary Fig. 1a), compared to that of single knockout or wild type
control thymocytes. Additionally, no signiﬁcant differences were
34 L.-N. Christina et al. / Immunology Letters 151 (2013) 31– 38
Fig. 1. Synergistic roles of PKC and PKC in IL-2 production. Impaired cytokine responses of PKC/ double knockout T cells are not caused by a secretion defect. (A)
Western blot analysis of wild type and PKC/ double knockout cells. Western blot shown is of whole cell lysates, with 5 × 106 naïve thymocytes or peripheral CD3+ T cells
per lane. Blots were stained with antibodies against PKC, , , , 	, PKB and Fyn (loading control). (B) Proliferative responses of PKC/ and PKC-deﬁcient CD3+ T cells
were analysed in comparison to wild type littermate controls. After incubation using different stimulatory conditions cells were analysed using standard procedures for
thymidine incorporation. (C) IL-2 responses of peripheral CD3+ T cells that were isolated from wild type, PKC single knockout, PKC single knockout and PKC/ double
knockout mice. Cells were stimulated with anti-CD3 (precoated), with or without anti-CD28, as indicated. Cytokine levels in cell culture supernatants were analysed after
48  h by Bioplex suspension array technology. (D) Analysis of secreted versus total IL-2 from wild type and PKC/ cells. Total IL-2 was determined after 3 cycles of freezing
a KC/
T ession
m
o
a
a
P
T
Ind thawing of cultured cells. (E) IL-2 gene expression is dramatically reduced in P
 cells were stimulated with anti-CD3 for a maximum of 20 h and IL-2 mRNA expr
ean  values of at least 2 independent experiments.
+ +bserved in the susceptibilities of CD4 and CD8 T cell blasts from
dult PKC/ double knockout mice to the ex vivo apoptotic stimuli
nti-CD3 or FasL, versus the susceptibilities of cells from PKC and
KC single knockout mice (supplementary Fig. 1b).
able 2
nduction of CD4+ and CD8+ effector memory cells, stimulation 20 h, n = 2 [percentage of 
Wt
CD4+ T cells
Medium  Naive cells (CD62L pos.) 83.58 ±
Medium  Effector memory cells (CD62L neg. CD44 pos.) 15.36 ±
CD3  + CD28 Naive cells (CD62L pos.) 31.96 ±
CD3  + CD28 Effector memory cells (CD62L neg. CD44 pos.) 68.33 ±
CD8+ T cells
Medium Naive cells (CD62L pos.) 70.87 ±
Medium  Effector memory cells (CD62L neg. CD44 pos.) 26.48 ±
CD3  + CD28 Naive  cells (CD62L pos.) 36.49 ±
CD3  + CD28 Effector memory cells (CD62L neg. CD44 pos.) 60.63 ± double-deﬁcient CD3+ T cells after CD3 stimulation. Wild type and mutant CD3+
, normalised to Gapdh, was  measured via real-time PCR. Results are shown as the3.3. Additive roles of PKC  ˛ and PKC  ˇ in de novo IL-2 synthesis
The  roles of PKC and PKC in IL-2 signalling were assessed by
the analyses of IL-2 mRNA expression and IL-2 protein secretion. In
naive and effector memory cells].
PKC−/− PKC−/− PKC−/−−/−
 2.49 83.45 ± 2.99 80.84 ± 0.46 86.92 ± 8.74
 6.02 15.31 ± 6.03 18.37 ± 6.84 12.10 ± 4.15
 4.27 39.39 ± 4.26 33.87 ± 4.85 33.26 ± 2.94
 1.97 60.58 ± 2.83 66.18 ± 1.78 66.52 ± 8.88
 16.44 70.29 ± 10.13 61.26 ± 13.90 73.10 ± 11.66
 17.53 27.18 ± 14.57 38.21 ± 17.10 25.32 ± 12.43
 16.97 42.71 ± 15.68 35.77 ± 18.26 38.63 ± 12.03
 17.87 52.53 ± 12.98 59.01 ± 16.30 57.51 ± 12.67
L.-N. Christina et al. / Immunology Letters 151 (2013) 31– 38 35
Fig. 2. (A and B) Loss of PKC and PKC in double-deﬁcient CD3+ T cells did not affect NFB, AP1 and NFAT DNA binding capacities. Nuclear extracts were prepared from
CD3+ T cells from wild type, PKC−/− , PKC−/− and PKC−/−−/− mice following stimulation with anti-CD3 with or without anti-CD28 for 16 h. Gel mobility shift assays were
performed with radioactively labelled probes that contained NFB, AP1 and NFAT binding site sequences. One representative experiment of 3 is shown. (C) Western blot
analysis of whole cell lysates from wild type, PKC−/− , PKC−/− and PKC−/−−/− CD3+ cells that were stimulated brieﬂy. Normal phosphorylation kinetics of IB, ERK and
P + f nucl −/− −/− −/− −/− +
w units 
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iKD were observed in single and double-deﬁcient CD3 T cells. (D) Immunoblot o
ere  stimulated as indicated for 16 h. Nuclear translocation of the p50 and p65 sub
hown.
ontrast to CD3+ T cells that were obtained from PKC and PKC
ingle knockout mice, which showed nearly normal IL-2 production
pon TCR stimulation [14,26], we observed a strong defect in IL-
 production in T cells from PKC/ double knockout mice upon
timulation with anti-CD3 alone (Fig. 1c), whereas the addition of
oluble anti-CD28 induced normal IL-2 levels from double knockout
 cells that were comparable to levels produced by wild type control
ells. These data indicate that the costimulatory CD28 signal can
omehow bypass the requirement for these cPKC isotypes during
CR signalling (data not shown).To investigate whether the signiﬁcantly reduced amounts of IL-2
n cell culture supernatants from PKC−/−−/− T cells were caused
y secretion defects, we performed “freeze and thaw” experiments,
n which IL-2 concentrations in cell culture supernatants (secretedear extracts from wild type, PKC , PKC and PKC  CD3 T cells that
of NFB was  normal in PKC−/−−/− T cells. One representative experiment of 2 is
IL-2)  were compared to the cytoplasmic IL-2 contents of the cells
plus supernatants (total IL-2), which were obtained by repeated
cycles of freezing and thawing of cells in order to disrupt them
and thus release stored IL-2. As shown in Fig. 1d, total IL-2 levels
were reduced to the same degree as secreted IL-2 levels, indicating
normal IL-2 secretion capacities in PKC/ double knockout cells.
However, quantitative RT-PCR analysis revealed signiﬁcant differ-
ences in IL-2 mRNA levels between wild type and mutant samples
(Fig. 1e). In contrast, there were no signiﬁcant differences between
wild type and knockout cells in the expression levels of mRNA for
IL5, IL-10, GM-CFS, IL-2RA and PKC (not  shown). Reduced IL-2
mRNA levels in PKC−/−−/− CD3+ T cells were not caused by faster
degradation, as the half-life of IL-2 mRNA was not decreased in
the mutant T cells (wt: 0.65 ± 0.07 h; PKC−/−−/−: 1.40 ± 1.27 h).
36 L.-N. Christina et al. / Immunology Letters 151 (2013) 31– 38
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ifferences were observed between wild type and PKC−/−−/− cells. Results are sh
hese data suggest that the combined PKC deﬁciency in T cells
electively affects de novo IL-2 mRNA transcription and IL-2 protein
xpression but not IL-2 mRNA stability or protein secretion.
.4.  No effects of the genetic losses of PKC  ˛ and PKC  ˇ on NFB,
FAT  and AP1 transactivation
To  understand the impaired IL-2 transcription, the DNA bind-
ng capacities of NFB, NFAT and AP1 to radioactively labelled IL-2ells that were stimulated or not with CD3 alone, CD3 + CD28 or CD3 + IL-2. No gross
s the mean ± SEM of 3 independent experiments.
promoter  oligos were studied via EMSAs. Interestingly, neither the
binding of NFB (Fig. 2a) nor of AP1 and NFAT (Fig. 2b) to DNA
were impaired in nuclear extracts from stimulated PKC−/−−/−T
cells. Immunoblot analysis of whole cell lysates demonstrated the
unimpaired phosphorylation of IB, as well as the normal phos-
phorylation and activation of ERK in PKC−/−−/− double-deﬁcient
CD3+ T cells (Fig. 2c). Data from the Western blot analysis of nuclear
extracts supported the observed normal DNA binding because
nuclear translocation of the NFB subunits p50 and p65 (and of
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FAT) was not reduced in mutant cells or in wild type cells upon
timulation with anti-CD3, with or without anti-CD28 (Fig. 2d).
aken together, these data indicate that PKC and PKC are not
nvolved in the control of CD3-induced transactivation of NFB,
FAT and AP1.
Consistently, the stimulation-dependent upregulation of the
urface markers CD25, CD69 and CD44, when monitored on CD3+
ells by FACS analysis, was not signiﬁcantly different between wild
ype, single knockout and PKC/ double knockout littermates
Fig. 3a and b); interestingly in the CD8+ subset the CD25 median
xpression was reproducibly reduced in PKC−/− and PKC−/−−/−
 cells (not shown). The effector/memory T cell ratio, deﬁned by
he surface expression of CD44 and CD62L, was unaltered by the
oncomitant loss of PKC and PKC (Table 2).
. Discussion
PKC has been proposed as a novel and key player in T cell acti-
ation via the stimulation of NFAT, AP1 and NFB, all of which
re transcription factors that are essential for IL-2 gene induc-
ion [27–31]. This has been conﬁrmed by experiments in which
KC-deﬁcient murine T cells showed profound defects in IL-2 pro-
uction upon TCR stimulation [8,9,32]. While the importance of
KC in T cell function is well documented in numerous in vitro
nd in vivo studies, an understanding of the roles of other PKC
amily members, which are normally expressed in T cells, in
CR-mediated cell activation remains elusive. Among the conven-
ional PKCs, PKC was shown to be essential for adequate T cell
roliferative responses upon CD3/CD28 stimulation. Interestingly,
espite profoundly reduced proliferation, IL-2 secretion was not
mpaired in CD3+ T cells that were obtained from PKC knockout
ice [14].
In  this study, we generated mice that lacked both conven-
ional PKC isotypes, PKC and PKC, and analysed the functions
f T cells from these mice to detect possible overlapping roles
f the two isotypes. As a result, we observed a strong defect in
he production of IL-2 in peripheral CD3+ T cells, independent of
KC function, in contrast to the normal levels of IL-2 that were
bserved in PKC and PKC single knockout cells, indicating that
oth PKC isotypes are required for the functional upregulation of
L-2. The isotypes have redundant roles, and each can compen-
ate for the loss of the other. The induction of IL-2 production
s under strict transcriptional regulation, which depends on the
rchestrated interplay of the NFB, NFAT and AP1 transcription
actors. Interestingly, the transactivation of NFB, NFAT and AP1
ere not affected by the combined loss of function of both PKC
sotypes.
Of note, the defect in IL-2 production was only observable when
 cells were stimulated with anti-CD3 alone, whereas full activation
ith CD28 costimulation rescued the proliferative and cytokine
ecretion defects of PKC/ cells to levels that were comparable to
hose observed in wild type and single knockout cells. This ﬁnding
uggests that TCR stimulation via anti-CD3 cross-linking requires
he classical PKC/ isotypes for the proper transcription of IL-2
RNA, whereas anti-CD28 costimulation, which has been shown
o be an important prerequisite for correct PKC localisation at the
entre of the immunological synapse (IS) [33,34], can bypass the
efect via the induction of PKC-mediated signalling pathways. IL-
 production can also be regulated at post-transcriptional levels
ia stabilising or destabilising processes at AU-rich repeats in the
′untranslated region of IL-2 mRNA.Because an impact of PKC on PMA  stimulation-induced IL-2
RNA stabilisation was  postulated by the work of Zhu et al. [35], we
ssessed the stability of IL-2 mRNA in actinomycin D-treated anti-
D3-stimulated PKC/-deﬁcient T cells via RT-PCR. Our analysis
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showed  directly that no increases in the instability or degradation
of IL-2 mRNA were detected in PKC/ T cells (data not shown).
It is known that high levels of IL-2 mRNA are transcribed prior
to cell division, while the transcription of IL-4 and IFN mRNA is
not induced strongly until after multiple cell cycles, when epige-
netic remodelling occurs [36,37]. Therefore, the slightly reduced
IL-4 mRNA levels that we observed seemed to be consequential
to impaired proliferation, while the defect in IL-2 synthesis was
the cause for reduced proliferation. However, where exactly cPKCs
interact in the IL-2 activation pathway remains unclear.
5.  Concluding remarks
Conventional  PKC and PKC play redundant roles in the acti-
vation of IL-2 transcriptional responses. Compared to PKC−/− and
PKC−/− single knockout cells, which show only slight reductions
in IL-2 secretion, IL-2 production is decreased dramatically in anti-
CD3-stimulated double-deﬁcient CD3+ T cells. In this study, we
found that low cytokine levels were caused by the decreased de
novo synthesis of IL-2 mRNA and not by increased mRNA instabil-
ity and degradation. For the ﬁrst time, we  demonstrate that besides
PKC, the cPKCs  and  are involved in CD3-induced T cell activa-
tion processes.
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